slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
35,92 CNY | +1,76% | +0,62% | -35,26% |
Vakgebied
Aantal werknemers: 579
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Enzymes and Reagents
45,7
%
| 132 | 49,9 % | 70 | 45,7 % | -47,02% |
Target and Factor Proteins
38,9
%
| 57 | 21,6 % | 60 | 38,9 % | +4,50% |
Clinical Research Organization Services
10,3
%
| 9 | 3,3 % | 16 | 10,3 % | +80,88% |
Recombinant Antibodies
5,0
%
| 66 | 25,1 % | 8 | 5,0 % | -88,53% |
Other Business
0,1
%
| 0 | 0,1 % | 0 | 0,1 % | -37,10% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
98,0
%
| 238 | 90,0 % | 150 | 98,0 % | -36,94% |
Overseas
2,0
%
| 26 | 10,0 % | 3 | 2,0 % | -88,51% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hua Xing Zhu
CEO | Chief Executive Officer | 52 | 07-09-09 |
Dong Ye Zhang
DFI | Director of Finance/CFO | 51 | 01-07-13 |
De Bin Li
CHM | Chairman | 38 | 01-07-12 |
Li Lan Cui
CTO | Chief Tech/Sci/R&D Officer | 34 | 01-07-15 |
Mi Wang
BRD | Director/Board Member | 34 | 01-06-15 |
Qing Yi Zhang
BRD | Director/Board Member | 39 | 01-07-11 |
Du Qiang Wang
BRD | Director/Board Member | 39 | 01-04-10 |
Yu Jian Zhao
BRD | Director/Board Member | 52 | 01-02-19 |
Ying Ming Wang
BRD | Director/Board Member | 49 | 01-10-09 |
Wen Luo Zhang
IRC | Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Fang Ping Zou
BRD | Director/Board Member | 50 | 01-10-09 |
Xia Yun Song
BRD | Director/Board Member | 55 | 15-04-21 |
Hua Xing Zhu
CEO | Chief Executive Officer | 52 | 07-09-09 |
Ying Ming Wang
BRD | Director/Board Member | 49 | 01-10-09 |
Yu Jian Zhao
BRD | Director/Board Member | 52 | 01-02-19 |
Du Qiang Wang
BRD | Director/Board Member | 39 | 01-04-10 |
Zong Xin Zhang
BRD | Director/Board Member | 52 | 15-04-21 |
Lin Hua
BRD | Director/Board Member | 42 | 15-04-21 |
Qing Yi Zhang
BRD | Director/Board Member | 39 | 01-07-11 |
Mi Wang
BRD | Director/Board Member | 34 | 01-06-15 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 70 175 439 | 16 424 379 ( 23,40 %) | 0 | 23,40 % |
Bedrijfsgegevens
Suzhou Novoprotein Scientific Co., Ltd.
3/F-4/F No. 228 Yunchuang Road
215299, Suzhou
+
http://www.novoprotein.com.cnSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-35,26% | 348 mln. | |
-2,19% | 89,87 mld. | |
-3,95% | 37,57 mld. | |
+63,05% | 26,47 mld. | |
-22,14% | 14,25 mld. | |
-7,96% | 12,99 mld. | |
-9,33% | 11,93 mld. | |
-46,33% | 10,84 mld. | |
+5,77% | 9,11 mld. | |
-17,66% | 7,32 mld. |
- Beurs
- Aandelen
- Koers 688137
- Onderneming Novoprotein Scientific Inc.